Apolipoprotein E ε4 Prevalence in Alzheimer’s Disease Patients Varies across Global Populations: A Systematic Literature Review and Meta-Analysis

Publisher： Karger

E-ISSN： 1421-9824|31|1|20-30

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.31, Iss.1, 2010-12, pp. : 20-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of Apolipoprotein E4 Genotype and Homozygotes (APOE e4/4) among Patients Diagnosed with Alzheimer’s Disease: A Systematic Review and Meta-Analysis

By  

Neuroepidemiology, Vol. 38, Iss. 1, 2011-12 ,pp. : 1-17

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Is Unrelated to Cognitive or Functional Decline in Alzheimer’s Disease: Retrospective and Prospective Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 1, 2006-06 ,pp. : 73-82

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Differently Affects the Patterns of Neuropsychological Presentation in Early- and Late-Onset Alzheimer’s Disease Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 2, 2004-08 ,pp. : 125-131

Karger

Access to resources Recommend Favorite

Effect of the Apolipoprotein E ε4 Allele on the Efficacy and Tolerability of Galantamine in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 1, 2005-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Differentiates the Clinical Response to Donepezil in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 20, Iss. 4, 2005-09 ,pp. : 254-261

Karger

Access to resources Recommend Favorite